Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
PTC Therapeutics, Inc. (PTCT)  
$77.26 0.59 (0.76%) as of 4:30 Fri 12/5


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,552,000
Market Cap: 7.00(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $36.19 - $86.25
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  557
Guru Rank Value     : 3.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 7,700
Total Buy Value $0 $0 $0 $198,736
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 408,401 426,136 576,037 859,971
Total Sell Value $28,645,946 $29,546,279 $37,208,492 $50,411,512
Total People Sold 7 8 11 13
Total Sell Transactions 20 24 65 100
End Date 2025-09-07 2025-06-06 2024-12-06 2023-12-07

   
Records found: 565
  Page 1 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-12-02 4 S $79.07 $271,052 D/D (3,428) 349,964 1%     
   Klein Matthew B. CHIEF EXECUTIVE OFFICER   •       •      –    2025-12-01 4 A $0.00 $0 D/D 15,625 353,392     -
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-11-25 4 AS $82.55 $6,001,932 D/D (71,928) 100,625 -7%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-11-25 4 OE $18.01 $2,211,679 D/D 71,928 112,024     -
   Jacobson Allan Steven   –       •      –    2025-11-25 4 AS $82.58 $1,186,282 D/D (14,199) 17,451 -7%     
   Jacobson Allan Steven   –       •      –    2025-11-25 4 OE $11.23 $213,017 D/D 14,199 25,351     -
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-11-24 4 AS $80.14 $2,852,031 D/D (35,572) 100,625 -3%     
   Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER   •       –      –    2025-11-24 4 OE $18.01 $1,075,296 D/D 35,572 106,726     -
   Jacobson Allan Steven   –       •      –    2025-11-24 4 AS $80.13 $945,736 D/D (11,801) 17,451 -3%     
   Jacobson Allan Steven   –       •      –    2025-11-24 4 OE $11.23 $173,883 D/D 11,801 23,551     -
   Reeve Emma   –       •      –    2025-11-21 4 AS $79.50 $795,000 D/D (10,000) 6,666 -2%     
   Reeve Emma   –       •      –    2025-11-21 4 OE $51.16 $511,600 D/D 10,000 16,666     -
   Okey Stephanie   –       •      –    2025-11-20 4 GD $0.00 $0 D/D 867 8,000     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-11-17 4 AS $75.64 $213,687 D/D (2,812) 103,901 2%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-11-17 4 OE $25.69 $72,240 D/D 2,812 106,713     -
   Reeve Emma   –       •      –    2025-11-12 4 AS $74.50 $546,309 D/D (7,333) 6,666 3%     
   Reeve Emma   –       •      –    2025-11-12 4 OE $46.54 $341,278 D/D 7,333 13,999     -
   Reeve Emma   –       •      –    2025-10-30 4 AS $69.50 $1,088,787 D/D (15,666) 6,666 13%     
   Reeve Emma   –       •      –    2025-10-30 4 OE $38.10 $457,200 D/D 12,000 18,666     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-07 4 AS $62.89 $214,091 D/D (3,375) 103,901 21%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-07 4 OE $38.10 $128,588 D/D 3,375 107,276     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-06 4 AS $65.07 $147,449 D/D (2,266) 103,901 19%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-06 4 OE $39.42 $89,326 D/D 2,266 106,167     -
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-03 4 AS $64.43 $1,491,100 D/D (22,655) 103,901 18%     
   Boulding Mark Elliott EXEC. VP AND CLO   •       –      –    2025-10-03 4 OE $39.42 $893,060 D/D 22,655 106,166     -

  565 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed